Google DeepMind

Foundation Models

Alphabet’s AI research lab, formed by merging DeepMind and Google Brain in 2023. Its models reach customers under Google’s name — Gemini, Veo and Imagen are priced and billed by Google, and nothing is sold under DeepMind’s own.

Subsidiary of Alphabet (Google)

Company disclosure · 17 Sep 2026
Total funding—
Valuation—
Employees—
Founded2010
HeadquartersLondon, United Kingdom
StatusAcquired
deepmind.google

Product

Selected offerings — the AI products recorded here, not the vendor's full catalogue.

Similar products 9

No sourced competitor yet: no filing, vendor document or measured-market report read so far names a rival for this company, so none is asserted. The companies below are the closest by what their products do.

How this list is ranked ↗

OwkinPrivate · $304.1M raisedAlphaFold Server and BiomarkerPlus do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale; ships AI agent and data service rather than the same layer.1 of 1 capabilityDifferent layerCompareInsilico MedicinePublic · $4.3BAlphaFold Server and inClinico do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale.1 of 1 capabilityShared product typeCompareChai DiscoveryPrivate · $3.8BAlphaFold Server and Chai Discovery platform do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale; ships platform rather than the same layer.1 of 1 capabilityDifferent layerCompareCradlePrivate · $103M raisedAlphaFold Server and Cradle do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale; ships platform rather than the same layer.1 of 1 capabilityDifferent layerCompareIsomorphic LabsPrivate · $2.7B raisedAlphaFold Server and Drug Design Engine do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale; ships platform rather than the same layer.1 of 1 capabilityDifferent layerCompareRecursion PharmaceuticalsPublic · $1.9BAlphaFold Server and Recursion OS do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale; ships platform rather than the same layer.1 of 1 capabilityDifferent layerCompareTempus AIPublic · $12.4BAlphaFold Server and Tempus Lens do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale.1 of 1 capabilityShared product typeCompareHuawei CloudPrivateAlphaFold Server and EIHealth do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale; Huawei Cloud's scale not recorded.1 of 1 capabilityShared product typeCompareNVIDIAPublic · $5.1TAlphaFold Server and NVIDIA BioNeMo do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale; ships hardware, infrastructure service and 2 more rather than the same layer.1 of 1 capabilityDifferent layerCompare

Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.

Sources

Founded

Regulatory filing · 17 Sep 2026

Companies House: DEEPMIND TECHNOLOGIES LIMITED, company number 07386350, incorporated 23 September 2010, status Active.

Status

Company disclosure · 17 Sep 2026

Alphabet-owned since the 2014 acquisition and merged with Google Brain in 2023; the ownership edge in relations.json carries the citation.

Description

Company disclosure · 17 Sep 2026

Own about page: Google DeepMind "brings together two of the world’s leading AI labs — Google Brain and DeepMind — into a single, focused team". NOTHING IS PURCHASABLE UNDER THE DEEPMIND NAME: the site names Gemini, Veo, Imagen, Gemma and AlphaFold but prices none of them, and the Gemini API is priced and billed by Google. The record says so rather than implying a product line it does not have. valuation and funding_total are bare: a wholly owned research subsidiary has neither.

Open Google DeepMind in the directory

Something wrong here? Send a correction — quote this company id: deepmind.